ALKS
AlkermesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ALKS vs peer average
79/100
ALKS vs. peer average (A vs. C)
Grade spread
A 3 · B 1 · C 2 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACAD is the first available peer comparator.
Closest CNS commercial peer for neuropsychiatry execution and specialty-pharma operating discipline; useful for read-through on promotional efficiency and payer traction.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALKS
Alkermes
ACAD
ACADIA
Grade
A
C
Momentum
84
27
Value
65
62
Sentiment
54
75
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ACAD
ALKS / ACAD
Grade Position
Above peers
ALKS vs. peer average (A vs. C)
79/100
Momentum
84
ALKSValue
65
ALKSSentiment
54
ACADRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALKS
ACAD is the first peer returned for this comparison set.

